Access Bio (Korea) Today
| 950130 Stock | KRW 6,550 170.00 2.66% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Access Bio is trading at 6550.00 as of the 19th of April 2024, a 2.66% increase since the beginning of the trading day. The stock's open price was 6380.0. Access Bio has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Access Bio are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Access Bio, Inc. researches, develops, and manufactures in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. The company has 26.79 M outstanding shares. More on Access Bio
Moving together with Access Stock
| 0.78 | 228670 | Ray Co | PairCorr |
| 0.83 | 263690 | DRGEM | PairCorr |
| 0.71 | 253840 | Sugentech | PairCorr |
Moving against Access Stock
| 0.85 | 000660 | SK Hynix Earnings Call This Week | PairCorr |
| 0.82 | 005935 | Samsung Electronics | PairCorr |
| 0.7 | 005930 | Samsung Electronics | PairCorr |
| 0.54 | 131030 | DHP Korea | PairCorr |
| 0.48 | 000270 | Kia Corp Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Access Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Access Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Access Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care Equipment & Supplies, Healthcare (View all Sectors) |
Access Bio (950130) is traded on KOSDAQ in Korea and employs 69 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 292.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Access Bio's market, we take the total number of its shares issued and multiply it by Access Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Access Bio operates under Healthcare sector and is part of Health Care Equipment & Supplies industry. The entity has 26.79 M outstanding shares.
Access Bio has accumulated about 167.93 M in cash with 137.9 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 828.78.
Check Access Bio Probability Of Bankruptcy
Ownership AllocationAccess Bio holds a total of 26.79 Million outstanding shares. Access Bio retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Access Ownership Details
Access Stock Price Odds Analysis
What are Access Bio's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Access Bio jumping above the current price in 90 days from now is about 98.0%. The Access Bio probability density function shows the probability of Access Bio stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Access Bio has a beta of -0.252. This suggests as returns on the benchmark increase, returns on holding Access Bio are expected to decrease at a much lower rate. During a bear market, however, Access Bio is likely to outperform the market. Additionally, access Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Access Bio to move above the current price in 90 days from now is about 98.0 (This Access Bio probability density function shows the probability of Access Stock to fall within a particular range of prices over 90 days) .
Access Bio Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Access Bio market risk premium is the additional return an investor will receive from holding Access Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Access Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Access Bio's alpha and beta are two of the key measurements used to evaluate Access Bio's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.52 | |||
| Standard Deviation | 2.24 | |||
| Variance | 5.03 | |||
| Risk Adjusted Performance | (0.11) |
Access Stock Against Markets
Picking the right benchmark for Access Bio stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Access Bio stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Access Bio is critical whether you are bullish or bearish towards Access Bio at a given time. Please also check how Access Bio's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Access Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Access Bio Corporate Management
Elected by the shareholders, the Access Bio's board of directors comprises two types of representatives: Access Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Access. The board's role is to monitor Access Bio's management team and ensure that shareholders' interests are well served. Access Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Access Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Gorman | B Board | Profile | |
| Terry Kim | Chief Africa | Profile | |
| Philip CPA | Treasurer Board | Profile | |
| John Kim | Managing Partner | Profile | |
| N MD | Clinical Board | Profile | |
| YoungHo Choi | CEO Pres | Profile | |
| Janet Strong | DODG Board | Profile |
How to buy Access Stock?
Before investing in Access Bio, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Access Bio. To buy Access Bio stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Access Bio. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Access Bio stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Access Bio stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Access Bio stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Access Bio, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Access Bio?
The danger of trading Access Bio is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Access Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Access Bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Access Bio is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Access Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Access Bio information on this page should be used as a complementary analysis to other Access Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Access Stock analysis
When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |